These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32155175)

  • 1. Epidemiological survey of serum titers from adults against various Gram-negative bacterial V-antigens.
    Kinoshita M; Shimizu M; Akiyama K; Kato H; Moriyama K; Sawa T
    PLoS One; 2020; 15(3):e0220924. PubMed ID: 32155175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. V-antigen homologs in pathogenic gram-negative bacteria.
    Sawa T; Katoh H; Yasumoto H
    Microbiol Immunol; 2014 May; 58(5):267-85. PubMed ID: 24641673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigens of the type-three secretion system of Aeromonas salmonicida subsp. salmonicida prevent protective immunity in rainbow trout.
    Bergh PV; Burr SE; Benedicenti O; von Siebenthal B; Frey J; Wahli T
    Vaccine; 2013 Oct; 31(45):5256-61. PubMed ID: 24012573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.
    Kinoshita M; Kato H; Yasumoto H; Shimizu M; Hamaoka S; Naito Y; Akiyama K; Moriyama K; Sawa T
    Hum Vaccin Immunother; 2016 Nov; 12(11):2833-2846. PubMed ID: 27454613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological analysis of serum anti-Pseudomonas aeruginosa PcrV titers in adults.
    Yasumoto H; Katoh H; Kinoshita M; Shimizu M; Hamaoka S; Akiyama K; Naito Y; Sawa T
    Microbiol Immunol; 2016 Feb; 60(2):114-20. PubMed ID: 26696420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and immunogenicity of a potential multivalent type III secretion system-based protein vaccine.
    Markham AP; Barrett BS; Esfandiary R; Picking WL; Picking WD; Joshi SB; Middaugh CR
    J Pharm Sci; 2010 Nov; 99(11):4497-509. PubMed ID: 20845449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive antibody cross-reactivity among infectious gram-negative bacteria revealed by proteome microarray analysis.
    Keasey SL; Schmid KE; Lee MS; Meegan J; Tomas P; Minto M; Tikhonov AP; Schweitzer B; Ulrich RG
    Mol Cell Proteomics; 2009 May; 8(5):924-35. PubMed ID: 19112181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analysis of inter-genus complexes of V-antigen and its regulator and their stabilization by divalent metal ions.
    Basu A; Das A; Mondal A; Datta S
    Eur Biophys J; 2016 Mar; 45(2):113-28. PubMed ID: 26463823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further characterization of a type III secretion system (T3SS) and of a new effector protein from a clinical isolate of Aeromonas hydrophila--part I.
    Sha J; Wang SF; Suarez G; Sierra JC; Fadl AA; Erova TE; Foltz SM; Khajanchi BK; Silver A; Graf J; Schein CH; Chopra AK
    Microb Pathog; 2007 Oct; 43(4):127-46. PubMed ID: 17644303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of cross-reacting protein antigen shared by Yersinia enterocolitica and other gram-negative bacteria with monoclonal antibody.
    Yamaguchi H; Taguchi H; Katura T; Kumada J; Uekusa T; Ogata S
    Microbiol Immunol; 1989; 33(8):683-8. PubMed ID: 2779474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis.
    Khan AA; Babu JP; Gupta G; Rao DN
    Vaccine; 2008 Jan; 26(3):316-32. PubMed ID: 18096277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of deletions in lcrV on secretion of V antigen, regulation of the low-Ca2+ response, and virulence of Yersinia pestis.
    Skrzypek E; Straley SC
    J Bacteriol; 1995 May; 177(9):2530-42. PubMed ID: 7730287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice.
    Sing A; Roggenkamp A; Geiger AM; Heesemann J
    J Immunol; 2002 Feb; 168(3):1315-21. PubMed ID: 11801671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of mice with YscF provides protection from Yersinia pestis infections.
    Matson JS; Durick KA; Bradley DS; Nilles ML
    BMC Microbiol; 2005 Jun; 5():38. PubMed ID: 15978133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria.
    Sato H; Frank DW
    Front Microbiol; 2011; 2():142. PubMed ID: 21772833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gram-negative pathogens and molecular mimicry: is there a case for mistaken identity? Response.
    Soloski MJ; Lo WF; Metcalf ES
    Trends Microbiol; 2000 Oct; 8(10):446-7. PubMed ID: 11203234
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis.
    Philipovskiy AV; Cowan C; Wulff-Strobel CR; Burnett SH; Kerschen EJ; Cohen DA; Kaplan AM; Straley SC
    Infect Immun; 2005 Mar; 73(3):1532-42. PubMed ID: 15731051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gram-negative pathogens and molecular mimicry: is there a case for mistaken identity?
    Albert LJ; Inman RD
    Trends Microbiol; 2000 Oct; 8(10):444-5. PubMed ID: 11044673
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.
    Sawa T; Ito E; Nguyen VH; Haight M
    Hum Vaccin Immunother; 2014; 10(10):2843-52. PubMed ID: 25483637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.